Unknown PHASE4 INTERVENTIONAL 2-arm NCT04725201

Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Interventions Intravenous unfractionated heparin Sham

Updated 9 times since 2021 Last updated: Jul 25, 2023 Started: May 24, 2021 Primary completion: Sep 24, 2024 Completion: May 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Amputation; Traumatic, Hand and is currently ongoing. Centre hospitalier de l'Université de Montréal (CHUM) leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Aug 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Aug 2023 — Jul 2024 [monthly]

Recruiting PHASE4
Sep 2022 — Aug 2023 [monthly]

Recruiting PHASE4

▶ Show 4 earlier versions

Sep 2021 — Sep 2022 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jun 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE4
May 2021 — Jun 2021 [monthly]

Not Yet Recruiting PHASE4
Feb 2021 — May 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre hospitalier de l'Université de Montréal (CHUM)

Data source: Centre hospitalier de l'Université de Montréal (CHUM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada